Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial
Authors:
- 1 February 2019
- journal article
- correction
- Published by Elsevier in The Lancet Neurology
- Vol. 18 (2) , 145-154
Abstract
No abstract availableKeywords
Funding Information
- Roche
- Parkinson Study Group
- CHDI Foundation
- ACADIA Pharmaceuticals
- National Institutes of Health
- Teva Pharmaceutical Industries
- Acorda Therapeutics
- National Institute of Neurological Disorders and Stroke
- St. Jude Medical
- School of Public Health, University of California, Berkeley
- Novartis
- US WorldMeds
- Abbott Laboratories
- Medical University of Silesia in Katowice
- H. Lundbeck A/S
- Pfizer
- International Parkinson and Movement Disorder Society
- AstraZeneca
- Sunovion
- Merck
- Adamas Pharmaceuticals
- American Parkinson Disease Association
- Kyowa Kirin Pharmaceutical Development
- National Parkinson Foundation
- AbbVie
- Kyowa Kirin
- Michael J. Fox Foundation for Parkinson's Research
This publication has 16 references indexed in Scilit:
- Effective Delivery of Apomorphine in the Management of Parkinson DiseaseClinical Neuropharmacology, 2015
- Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamicsMovement Disorders, 2014
- The long-duration response to levodopa: Phenomenology, potential mechanisms and clinical implicationsParkinsonism & Related Disorders, 2011
- Levodopa for the Treatment of Parkinson's DiseaseNew England Journal of Medicine, 2008
- Interaction revisited: the difference between two estimatesBMJ, 2003
- Spirometric Reference Values from a Sample of the General U.S. PopulationAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Core assessment program for intracerebral transplantations (CAPIT)Movement Disorders, 1992
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975